Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 26.23%-28.69M | ---- | -3.44%-38.89M | ---- | -56.80%-37.59M | ---- | -62.33%-23.98M | ---- | -457.51%-14.77M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 65.67%-13.9K | ---- | -723.57%-40.5K | ---- | -881.44%-4.92K | ---- | 98.72%-501 | ---- | 68.63%-39.27K |
| Impairment and provisions: | ---- | -56.82%5.47M | ---- | -17.81%12.66M | ---- | -15.14%15.4M | ---- | 142.29%18.15M | ---- | --7.49M |
| -Impairment of property, plant and equipment (reversal) | ---- | 100.43%4.79M | ---- | -84.33%2.39M | ---- | -13.09%15.25M | ---- | --17.55M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.93%5.3K | ---- | --7.49M |
| -Other impairments and provisions | ---- | -93.41%676.59K | ---- | 6,585.32%10.27M | ---- | -74.37%153.6K | ---- | --599.39K | ---- | ---- |
| Asset sale loss (gain): | ---- | -73.36%1.47M | ---- | -14.54%5.52M | ---- | 489.99%6.46M | ---- | 98.25%1.09M | ---- | 1,442.56%552.05K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | --4.07M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -73.36%1.47M | ---- | 130.87%5.52M | ---- | 118.38%2.39M | ---- | 98.25%1.09M | ---- | 1,442.56%552.05K |
| Depreciation and amortization: | ---- | -33.58%4.11M | ---- | -29.36%6.18M | ---- | 2.71%8.75M | ---- | -19.57%8.52M | ---- | 15.00%10.59M |
| -Depreciation | ---- | -40.30%3.42M | ---- | -30.58%5.72M | ---- | -3.24%8.24M | ---- | -12.83%8.52M | ---- | 23.11%9.77M |
| Financial expense | ---- | -50.72%389.46K | ---- | -42.79%790.34K | ---- | -23.63%1.38M | ---- | 11.91%1.81M | ---- | -46.19%1.62M |
| Operating profit before the change of operating capital | ---- | -25.34%-17.27M | ---- | -145.67%-13.78M | ---- | -200.23%-5.61M | ---- | 2.83%5.6M | ---- | -74.24%5.44M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -99.70%2.21K | ---- | 204.24%739.33K | ---- | 888.42%243.01K | ---- | 122.24%24.59K | ---- | -143.36%-110.56K |
| Accounts receivable (increase)decrease | ---- | -206.37%-1.14M | ---- | -87.05%1.07M | ---- | 3,654.73%8.3M | ---- | 99.11%-233.43K | ---- | -444.41%-26.33M |
| Accounts payable increase (decrease) | ---- | 257.81%8.02M | ---- | 199.69%2.24M | ---- | -18.77%-2.25M | ---- | -140.67%-1.89M | ---- | 272.70%4.65M |
| Cash from business operations | ---- | -6.89%-10.39M | ---- | -1,521.50%-9.72M | ---- | -80.43%684.11K | ---- | 121.38%3.49M | ---- | -218.02%-16.34M |
| Special items of business | -73.51%-10.93M | 150.33%3.05M | -251.15%-6.3M | -434.38%-6.07M | -151.57%-1.79M | 121.56%1.81M | 147.49%3.48M | ---8.41M | -905.87%-7.32M | ---- |
| Net cash from operations | -73.51%-10.93M | 53.50%-7.34M | -251.15%-6.3M | -732.11%-15.79M | -151.57%-1.79M | 150.80%2.5M | 147.49%3.48M | 69.91%-4.92M | -905.87%-7.32M | -218.02%-16.34M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -65.67%13.9K | ---- | 985.08%40.5K | ---- | 62,100.00%3.73K | ---- | -99.98%6 | ---- | -70.51%33.23K |
| Decrease in deposits (increase) | ---- | 7.48%1.51M | ---- | --1.41M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | -86.47%4.82M | ---- | 463.68%35.63M | ---- | -58.55%6.32M | ---- | 30.42%15.25M | --13.8M | 1,682.74%11.69M |
| Purchase of fixed assets | ---- | 30.78%-4.44M | ---- | -475.66%-6.41M | ---- | 79.00%-1.11M | ---- | 81.21%-5.3M | 81.01%-3.65M | -35.52%-28.23M |
| Sale of subsidiaries | ---- | ---- | ---- | 6,687.90%3M | ---- | ---45.54K | ---- | ---- | ---- | ---- |
| Other items in the investment business | 60.54%-643.57K | ---- | -124.57%-1.63M | ---- | 1,202.84%6.64M | ---- | -104,219.55%-601.81K | --581 | -98.26%578 | ---- |
| Net cash from investment operations | 60.54%-643.57K | -94.32%1.91M | -124.57%-1.63M | 551.79%33.67M | 1,202.84%6.64M | -48.08%5.17M | -105.93%-601.81K | 160.29%9.95M | 152.95%10.15M | 17.75%-16.5M |
| Net cash before financing | -45.94%-11.57M | -130.36%-5.43M | -263.73%-7.93M | 133.32%17.88M | 68.39%4.84M | 52.31%7.66M | 1.68%2.88M | 115.32%5.03M | 115.49%2.83M | -428.61%-32.85M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 7,232.78%3.03M | ---- | --41.3K | ---- | ---- | ---- | 18.91%11.89M | 18.91%11.89M | --10M |
| Refund | ---- | 52.85%-2.48M | ---- | -92.04%-5.27M | ---- | 75.93%-2.74M | ---- | -103.71%-11.4M | -78.76%-10M | -135.71%-5.59M |
| Issuing shares | ---- | --3.05M | ---- | ---- | ---- | -73.60%3.96M | ---- | 104.92%15M | ---- | -91.13%7.32M |
| Interest paid - financing | ---- | 51.17%-385.95K | ---- | 42.79%-790.34K | ---- | 23.63%-1.38M | ---- | -11.91%-1.81M | -21.13%-845.08K | 36.40%-1.62M |
| Issuance expenses and redemption of securities expenses | ---- | ---45.98K | ---- | ---- | ---- | 49.72%-186.16K | ---- | -31.17%-370.23K | ---- | 97.85%-282.25K |
| Other items of the financing business | 3,263.40%7.74M | ---- | 103.46%230.25K | ---- | -260.35%-6.65M | ---- | ---1.84M | ---- | ---- | ---- |
| Net cash from financing operations | 3,263.40%7.74M | 100.55%77.65K | 103.46%230.25K | -67.43%-14.23M | -260.35%-6.65M | -204.37%-8.5M | 27.21%-1.84M | 295.53%8.14M | -5,574.71%-2.53M | -93.82%2.06M |
| Effect of rate | 89.00%-9.19K | ---6.44K | ---83.51K | ---- | ---- | 475.00%270 | --270 | ---72 | ---- | ---- |
| Net Cash | 50.28%-3.83M | -246.47%-5.35M | -327.09%-7.7M | 538.27%3.65M | -274.71%-1.8M | -106.33%-833.69K | 249.88%1.03M | 142.79%13.17M | 101.61%294.93K | -213.66%-30.79M |
| Begining period cash | -48.20%5.76M | 48.96%11.12M | 48.96%11.12M | -10.05%7.46M | -10.05%7.46M | 270.10%8.3M | 270.10%8.3M | -118.82%-4.88M | -118.82%-4.88M | 2,302.18%25.91M |
| Cash at the end | -42.38%1.92M | -48.20%5.76M | -41.10%3.33M | 48.96%11.12M | -39.32%5.66M | -10.05%7.46M | 303.58%9.33M | 270.10%8.3M | -160.27%-4.58M | -118.82%-4.88M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Hang Kin Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.